Sublingual Semaglutide Suspension
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Indications include blood sugar control, obesity, and treatment for type-2 diabetes.
The sublingual administration route is particularly beneficial as it bypasses the gastrointestinal system, avoiding degradation of the active pharmaceutical ingredient (API) and minimizing absorption variability. This is especially advantageous for Semaglutide, ensuring consistent and reliable drug delivery, critical for maintaining its therapeutic efficacy in managing type-2 diabetes and supporting weight management.
Semaglutide is available by prescription only. Always consult with a healthcare professional before taking any medication.